Wuhan YZY MEDICAL Science and Technology

Wuhan YZY Medical Science and Technology Co. Ltd,(YZY MED). was founded in 2011, with personalized diagnosis and treatment of cardiovascular, tumor as the strategic direction, YZY Med is a high-tech enterprise specializing in the R&D, production and sales of individualized medical diagnostic products. The company has established various technical platforms, including ARMS fluorescence quantitative PCR, multiple fluorescence quantitative PCR, nucleic acid mass spectrometry, fluorescence in situ hybridization(FISH) and circulating tumor cell(CTC) detection, etc. Meanwhile, the self-developed products include molecular diagnostic products to guide personalized medicine for cardiovascular and cerebrovascular diseases, companion diagnostic products to guide tumor diagnosis and treatment, FISH products and circulating tumor cell (CTC) Autoanalyzer System, all these provide clinical diagnosis basis for precision medicine.

The company has successfully developed over 160 genetic diagnostic products and multiple in vitro diagnostic (IVD) devices, among which 14 molecular diagnostic kits have been approved by the NMPA Class III medical device registration and approval, and 110 products have passed the CE certification.

※Ranked First in Domestic Market of Molecular Diagnostics for PGx

※Complete Target Certificates for CDx Detection Kits

※The First Autoanalyzer System on CTC Certified in China

※Complete and Customizable FISH Probes with CE Certificates

Mission: The Right Drug for The Right Patient

Vision：To become a leading enterprise in the field of personalized medicine.

Create an excellent platform to realize self value to contribute back to society.

Core Values : Integrity, Proactive, Cooperation, Innovation